RecruitingNCT06078865
FX Shoulder Prospective Clinical Study
FX Shoulder Post-Market Follow-Up Clinical Study
Sponsor
FX Shoulder Solutions
Enrollment
600 participants
Start Date
Mar 31, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
Prospective Multi-Center Registry on study subjects with implanted devices marketed and legally commercialized in the USA by FX Shoulder Solutions.
Eligibility
Inclusion Criteria1
- Receive an FX shoulder replacement medical device in accordance with the Indications for Use for the selected device system.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEFX Artificial Shoulder Prosthesis
Humelock II Anatomic Shoulder System, Humelock II Reversible Shoulder System, Humelock Reverse Shoulder System, Humeris Shoulder System, Easytech Anatomical Shoulder System, FXV135 Mini Shoulder System, FXV135 Humelock Shoulder System
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06078865
Related Trials
Perform Humeral System Study
NCT0506754310 locations
The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis
NCT049299511 location
Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty
NCT049684053 locations
Prophylactic Conjoint Tendon Lengthening During Reverse Shoulder Arthroplasty Outcomes
NCT067299831 location
Embo Registry; National Registry for Artery Embolization
NCT064779652 locations